• Events Calendar
    • Cell & Gene
    • Oligonucleotides
    • Peptides
    • Proteins, Antibodies & ADCs
    • Vaccines
    • Drug Discovery
    • Drug Development
    • Manufacturing & Production
    • Commercialisations & Supply Chain
    • News, Articles & Whitepapers
    • Market Insight
    • Thought Leadership
    • Technology Spotlight
  • About Us
Register Sign In
  • Events Calendar
  • Therapeutic Modality
      Cell & Gene
      Oligonucleotides
      Peptides
      Proteins, Antibodies & ADCs
      Vaccines
  • Pipeline Stage
      Drug Discovery
      Drug Development
      Manufacturing & Production
      Commercialisations & Supply Chain
  • Format
      News, Articles & Whitepapers
      Market Insight
      Thought Leadership
      Technology Spotlight
  • About Us
    Search
Sign In
News Proteins, Antibodies & ADCs

Interview with Patrick Lucy

3 November, 2026
Read time: 8 mins
Watch this next
Proteins, Antibodies & ADCs

Panel Discussion: Mastering Stability & Characterisation: Building Confidence In Protein & Antibody Therapeutics From Bench To Batch

Christian Hunzinger BioNTech
Fabio Centola Merck KGaA
Dennis Ungan Novartis
Market Insight
Jul, 2026
Proteins, Antibodies & ADCs

Panel Discussion: Next-Generation Biomed: AI, Science, Or The People Behind – What Will Actually Scale?

Russell Lamontagne Boston Immune Technologies
Yashas Kannan PentaBind
Catherine Stace Kuano
Market Insight
Jul, 2026
Proteins, Antibodies & ADCs

Panel Discussion: Next-Generation Modalities & Biotherapeutics: From Idea To Implementation

Miguel Gaspar AstraZeneca
Steve Hood GSK
Christopher Herring T-Therapeutics
Michelle Barnard ValiRx
Jennifer Mataraza Novartis
Market Insight
Jul, 2026
News
Interview with Adriana Kiedzierska-Mencfeld

Interview with Adriana Kiedzierska-Mencfeld

Proteins, Antibodies & ADCs
Nov, 2026
Mechanism-Guided ADC Characterization for Candidate Optimization & Differentiation

Mechanism-Guided ADC Characterization for Candidate Optimization & Differentiation

Proteins, Antibodies & ADCs
Sep, 2026
ADC Drug Discovery: Target Biology, Antibody Discovery, and In Vitro & In Vivo Characterization

ADC Drug Discovery: Target Biology, Antibody Discovery, and In Vitro & In Vivo Characterization

Proteins, Antibodies & ADCs
Sep, 2026
In Vitro Assays for ADC Discovery: From Design to Translational Insights

In Vitro Assays for ADC Discovery: From Design to Translational Insights

Proteins, Antibodies & ADCs
Sep, 2026
ADC Characterization and Differentiation via Comprehensive In Vitro & In Vivo Strategies

ADC Characterization and Differentiation via Comprehensive In Vitro & In Vivo Strategies

Proteins, Antibodies & ADCs
Sep, 2026
Interview with Ulrich Rümenapp

Interview with Ulrich Rümenapp

Proteins, Antibodies & ADCs
Sep, 2026
Interview with Charlotte Deane

Interview with Charlotte Deane

Proteins, Antibodies & ADCs
Mar, 2026
Interview with Karen Silence

Interview with Karen Silence

Proteins, Antibodies & ADCs
Mar, 2026
  • Events
    About Us
    Contact Us
    FAQ
    Privacy Policy
    Terms and Conditions
    Cookie Policy
    Manage Cookies
  • Cell & Gene
    Oligonucleotides
    Peptides
    Proteins, Antibodies & ADCs
    Vaccines
  • Drug Discovery
    Drug Development
    Manufacturing & Production
    Commercialisation & Supply Chain
  • News
    Market Insight
    Technology Spotlight
    Thought Leadership
  • Discovery & Development
    NextGen Biomed
    Precision Medicine
    Oxford Global
© 2026 Oxford Global Ltd. All rights reserved.
Designed & built by Standfirst

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.